While the outcomes can be positive, Consumer Reports warns there are important considerations, especially for older adults, ...

Coverage complications are not unusual in the U.S. health care system. But the challenge is magnified for these obesity ...

Supplies of high-demand obesity drugs are improving – but they’re not easier to get - ‘There are a lot of people right now ...

This will be a “pivotal year,” one expert says, for GLP-1 drugs, which are massively disrupting the benefits landscape.

Two Omaha women lost more than 300 lbs. combined with injections of a GLP-1 drug, which are used increasingly for weight loss ...